Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aclaris Therapeutics (ACRS) Goodwill (2017 - 2019)

Aclaris Therapeutics (ACRS) has 3 years of Goodwill data on record, last reported at $18.5 million in Q4 2019.

  • For Q4 2019, Goodwill changed 0.0% year-over-year to $18.5 million; the TTM value through Dec 2019 reached $18.5 million, changed 0.0%, while the annual FY2019 figure was $18.5 million, 0.0% changed from the prior year.
  • Goodwill reached $18.5 million in Q4 2019 per ACRS's latest filing, roughly flat from $18.5 million in the prior quarter.
  • Across five years, Goodwill topped out at $18.5 million in Q4 2017 and bottomed at $18.5 million in Q4 2017.
  • Average Goodwill over 3 years is $18.5 million, with a median of $18.5 million recorded in 2017.
  • The widest YoY moves for Goodwill: up 0.0% in 2018, down 0.0% in 2018.
  • A 3-year view of Goodwill shows it stood at $18.5 million in 2017, then changed by 0.0% to $18.5 million in 2018, then changed by 0.0% to $18.5 million in 2019.
  • Per Business Quant database, its latest 3 readings for Goodwill were $18.5 million in Q4 2019, $18.5 million in Q1 2019, and $18.5 million in Q4 2018.